Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
GSK2251052 (formerly AN3365)
print preview
bookmark
share with colleague
General Information
Company
Anacor Pharmaceuticals Inc.
Description
Boron-based, small-molecule antibiotic targeting the bacterial enzyme leucyl-tRNA synthetase (LARS; LeuRS)
Molecular Target
Leucyl-tRNA synthetase (LARS) (LeuRS)
Mechanism of Action
Leucyl-tRNA synthetase inhibitor
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Disease Category
Standard Indication
Indication Details
Partners
Milestones
Latest Stage of Development
More
Archive Items are loading
Set Email Alert
dummy